← Every applicant
Scinopharm Taiwan FDA Approvals
3 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| GLATIRAMER ACETATENew drugDec 31, 2025INJECTABLE, SUBCUTANEOUS |
| CLOFARABINENew drugJan 3, 2025SOLUTION, INTRAVENOUS |
| BORTEZOMIBNew drugSep 26, 2023INJECTABLE, INTRAVENOUS, SUBCUTANEOUS |